For patients with iliac artery blockages, treatment with a self-expanding stent provides better protection against restenosis at 12 months and no reduction in safety compared with a balloon-expandable ...
BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.
BD’s Revello Vascular Covered Stent receives CE marking to treat atherosclerotic lesions in common and external iliac arteries: Franklin Lakes, New Jersey Monday, March 9, 2026, ...
DUBLIN -- Medtronic plc today announced that its Protégé(TM) GPS(TM) self-expanding peripheral stent system has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...
ABBOTT PARK, Ill., Aug. 7, 2012 /PRNewswire/ -- Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the Omnilink Elite ® Vascular Balloon-Expandable Stent System for the ...
BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...
Several balloon-expandable stents have been used in the iliac artery, however, they have not had a primary indication for iliac stenting. The Express® LD iliac premounted stent system (Boston ...
Iliac venous outflow obstruction has an important role in the expression of symptomatic chronic venous insufficiency. This anatomic obstruction is frequently overlooked, owing in part to diagnostic ...
The Revello™ Vascular Covered Stent is designed to combine the flexibility of a nitinol self-expanding stent with the radial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results